Champions Oncology's Total Assets for the quarter that ended in Jan. 2025 was $30.63 Mil.
Warning Sign:
If a company builds assets at 24% a year, faster than its revenue growth rate of 14.2% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Champions Oncology's average Total Assets Growth Rate was 22.90% per year.
During the past 3 years, the average Total Assets Growth Rate was 0.90% per year.
During the past 5 years, the average Total Assets Growth Rate was 24.00% per year.
During the past 10 years, the average Total Assets Growth Rate was 30.40% per year.
During the past 13 years, Champions Oncology's highest 3-Year average Total Assets Growth Rate was 96.20%. The lowest was -29.30%. And the median was 16.00%.
The historical data trend for Champions Oncology's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Champions Oncology's Total Assets for the fiscal year that ended in Apr. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Champions Oncology (NAS:CSBR) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Jan. 2025) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Champions Oncology's Asset Turnover for the quarter that ended in Jan. 2025 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Champions Oncology Total Assets Related Terms
Thank you for viewing the detailed overview of Champions Oncology's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CSBR has been successfully added to your 